151 related articles for article (PubMed ID: 36563611)
1. P50 inhibition defects, psychopathology and gray matter volume in patients with first-episode drug-naive schizophrenia.
Lang X; Wang D; Zhou H; Wang L; Kosten TR; Zhang XY
Asian J Psychiatr; 2023 Feb; 80():103421. PubMed ID: 36563611
[TBL] [Abstract][Full Text] [Related]
2. P50 inhibition defects with psychopathology and cognitive impairment in patients with first-episode drug naïve schizophrenia.
Xia L; Wang D; Wei G; Wang J; Zhou H; Xu H; Tian Y; Dai Q; Xiu M; Chen D; Wang L; Zhang X
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110246. PubMed ID: 33453321
[TBL] [Abstract][Full Text] [Related]
3. P50 sensory gating, cognitive deficits and depressive symptoms in first-episode antipsychotics-naïve schizophrenia.
Li S; Yu B; Wang D; Xia L; Wang L; Chen D; Xiu M; Zhang XY
J Affect Disord; 2023 Mar; 324():153-161. PubMed ID: 36587903
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional brain abnormalities in schizophrenia: A cross-sectional study at different stages of the disease.
Zhao C; Zhu J; Liu X; Pu C; Lai Y; Chen L; Yu X; Hong N
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():27-32. PubMed ID: 29292241
[TBL] [Abstract][Full Text] [Related]
5. Correlations between exploratory eye movement, hallucination, and cortical gray matter volume in people with schizophrenia.
Qiu L; Yan H; Zhu R; Yan J; Yuan H; Han Y; Yue W; Tian L; Zhang D
BMC Psychiatry; 2018 Jul; 18(1):226. PubMed ID: 30005610
[TBL] [Abstract][Full Text] [Related]
6. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.
Lui S; Deng W; Huang X; Jiang L; Ma X; Chen H; Zhang T; Li X; Li D; Zou L; Tang H; Zhou XJ; Mechelli A; Collier DA; Sweeney JA; Li T; Gong Q
Am J Psychiatry; 2009 Feb; 166(2):196-205. PubMed ID: 18981063
[TBL] [Abstract][Full Text] [Related]
7. Smoking affects the association between cognitive impairment and P50 inhibition defects in patients with chronic schizophrenia: A case-control study.
Wang DM; Xia LY; Zhou HX; Tian Y; Dai QL; Xiu MH; Chen DC; Wang L; Zhang XY
Asian J Psychiatr; 2023 Jan; 79():103391. PubMed ID: 36516649
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in P50 inhibition defects with psychopathology and cognition in patients with first-episode schizophrenia.
Xia L; Liu R; Zhou H; Tian Y; Dai Q; Xiu M; Chen D; Wang D; Zhang X
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110380. PubMed ID: 34111493
[TBL] [Abstract][Full Text] [Related]
9. Sensory Gating Deficits and their Clinical Correlates in Drug-Free/Drug-Naive Patients with Schizophrenia.
Karkal R; Goyal N; Tikka SK; Khanande RV; Kakunje A; Khess CRJ
Indian J Psychol Med; 2018; 40(3):247-256. PubMed ID: 29875532
[TBL] [Abstract][Full Text] [Related]
10. Gray matter volume changes following antipsychotic therapy in first-episode schizophrenia patients: A longitudinal voxel-based morphometric study.
Guo F; Zhu YQ; Li C; Wang XR; Wang HN; Liu WM; Wang LX; Tian P; Kang XW; Cui LB; Xi YB; Yin H
J Psychiatr Res; 2019 Sep; 116():126-132. PubMed ID: 31233895
[TBL] [Abstract][Full Text] [Related]
11. [The follow-up study on P50 auditory sensory gating in naïve schizophrenia].
Wang HX; Zhang MD; Wang ZC; Chen XS; Lou FY; Liang JH; Chen C
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):601-5. PubMed ID: 20450782
[TBL] [Abstract][Full Text] [Related]
12. P50 inhibition deficit in patients with chronic schizophrenia: Relationship with cognitive impairment of MATRICS consensus cognitive battery.
Xia L; Yuan L; Du XD; Wang D; Wang J; Xu H; Huo L; Tian Y; Dai Q; Wei S; Wang W; Trihn TH; Alnatour OI; Chen D; Xiu M; Wang L; Yang M; Zhang XY
Schizophr Res; 2020 Jan; 215():105-112. PubMed ID: 31780341
[TBL] [Abstract][Full Text] [Related]
13. Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness.
Torres US; Duran FL; Schaufelberger MS; Crippa JA; Louzã MR; Sallet PC; Kanegusuku CY; Elkis H; Gattaz WF; Bassitt DP; Zuardi AW; Hallak JE; Leite CC; Castro CC; Santos AC; Murray RM; Busatto GF
Neuroimage Clin; 2016; 12():1-15. PubMed ID: 27354958
[TBL] [Abstract][Full Text] [Related]
14. The interaction between first-episode drug-naïve schizophrenia and age based on gray matter volume and its molecular analysis: a multimodal magnetic resonance imaging study.
Chen J; Wei Y; Xue K; Han S; Wang C; Wen B; Cheng J
Psychopharmacology (Berl); 2023 Apr; 240(4):813-826. PubMed ID: 36719459
[TBL] [Abstract][Full Text] [Related]
15. Grey matter volume reduction in the frontotemporal cortex associated with persistent verbal auditory hallucinations in Chinese patients with chronic schizophrenia: Insights from a 3 T magnetic resonance imaging study.
Ren H; Li J; Zhou J; Chen X; Tang J; Li Z; Wang Q
Schizophr Res; 2024 Jul; 269():123-129. PubMed ID: 38772324
[TBL] [Abstract][Full Text] [Related]
16. Absence of negative associations of insular and medial frontal gray matter volume with dissociative symptoms in schizophrenia.
Tseng HH; Chiu CD; Chen KC; Lee IH; Chen PS; Yang YK
J Psychiatr Res; 2021 Jun; 138():485-491. PubMed ID: 33965737
[TBL] [Abstract][Full Text] [Related]
17. Association of reduced cortical thickness and psychopathological symptoms in patients with first-episode drug-naïve schizophrenia.
Zhou H; Wang D; Cao B; Zhang X
Int J Psychiatry Clin Pract; 2023 Mar; 27(1):42-50. PubMed ID: 36193901
[TBL] [Abstract][Full Text] [Related]
18. Brain structural alterations associated with impulsiveness in male violent patients with schizophrenia.
Lu J; Gou N; Sun Q; Huang Y; Guo H; Han D; Zhou J; Wang X
BMC Psychiatry; 2024 Apr; 24(1):281. PubMed ID: 38622613
[TBL] [Abstract][Full Text] [Related]
19. Factor analysis of lifetime psychopathology and its brain morphometric and genetic correlates in a transdiagnostic sample.
Krug A; Stein F; David FS; Schmitt S; Brosch K; Pfarr JK; Ringwald KG; Meller T; Thomas-Odenthal F; Meinert S; Thiel K; Winter A; Waltemate L; Lemke H; Grotegerd D; Opel N; Repple J; Hahn T; Streit F; Witt SH; Rietschel M; Andlauer TFM; Nöthen MM; Philipsen A; Nenadić I; Dannlowski U; Kircher T; Forstner AJ
Transl Psychiatry; 2024 Jun; 14(1):235. PubMed ID: 38830892
[TBL] [Abstract][Full Text] [Related]
20. Differential Cortical Gray Matter Deficits in Adolescent- and Adult-Onset First-Episode Treatment-Naïve Patients with Schizophrenia.
Zhang C; Wang Q; Ni P; Deng W; Li Y; Zhao L; Ma X; Wang Y; Yu H; Li X; Zhang P; Meng Y; Liang S; Li M; Li T
Sci Rep; 2017 Aug; 7(1):10267. PubMed ID: 28860557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
